{
  "id": 16603653,
  "title": "Mankind Pharma Q2 PAT rises 37.7% on strong domestic chronic business",
  "url": "https://urgent.news/2026/10/26/mankind-pharma-q2-pat-rises-37-7-on-strong-domestic-chronic-business",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T12:12:33.000Z",
  "source": {
    "name": "Business Standard IN",
    "slug": "business-standard-in",
    "url": "https://www.business-standard.com/companies/quarterly-results/mankind-pharma-q2-pat-rises-37-7-on-strong-domestic-chronic-business-126102601083_1.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The drugmaker's revenue rose 17.3 per cent to ₹4,338 crore in Q2 FY27, supported by strong demand for chronic therapies and growth in Bharat Serums and Vaccines' speciality portfolio.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}